Instrument NameCardiol Therapeutics IncInstrument Symbol(CRDL-T)

Instrument ExchangeTSX

Cardiol Therapeutics Inc is a clinical-stage life sciences company developing therapies for cardiovascular disease (CVD). The lead product, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation being investigated in Phase II/III study, the LANCER trial. The CardiolRx is also being investigated in patients with acute myocarditis and recurrent pericarditis.